180 related articles for article (PubMed ID: 19109135)
1. Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation.
McCarron M; Reen DJ
J Immunol; 2009 Jan; 182(1):55-62. PubMed ID: 19109135
[TBL] [Abstract][Full Text] [Related]
2. TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation.
Cottalorda A; Verschelde C; Marçais A; Tomkowiak M; Musette P; Uematsu S; Akira S; Marvel J; Bonnefoy-Berard N
Eur J Immunol; 2006 Jul; 36(7):1684-93. PubMed ID: 16761317
[TBL] [Abstract][Full Text] [Related]
3. Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model.
Nguyen CT; Hong SH; Sin JI; Vu HV; Jeong K; Cho KO; Uematsu S; Akira S; Lee SE; Rhee JH
Vaccine; 2013 Aug; 31(37):3879-87. PubMed ID: 23831323
[TBL] [Abstract][Full Text] [Related]
4. Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
Schmitt S; Tahk S; Lohner A; Hänel G; Maiser A; Hauke M; Patel L; Rothe M; Josenhans C; Leonhardt H; Griffioen M; Deiser K; Fenn NC; Hopfner KP; Subklewe M
Front Immunol; 2020; 11():602802. PubMed ID: 33281829
[TBL] [Abstract][Full Text] [Related]
5. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells.
Caron G; Duluc D; Frémaux I; Jeannin P; David C; Gascan H; Delneste Y
J Immunol; 2005 Aug; 175(3):1551-7. PubMed ID: 16034093
[TBL] [Abstract][Full Text] [Related]
6. Prior TLR5 induction in human T cells results in a transient potentiation of subsequent TCR-induced cytokine production.
Tremblay MM; Bilal MY; Houtman JC
Mol Immunol; 2014 Feb; 57(2):161-70. PubMed ID: 24128895
[TBL] [Abstract][Full Text] [Related]
7. Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells.
van Aubel RA; Keestra AM; Krooshoop DJ; van Eden W; van Putten JP
Mol Immunol; 2007 Jul; 44(15):3702-14. PubMed ID: 17493681
[TBL] [Abstract][Full Text] [Related]
8. Src kinases central to T-cell receptor signaling regulate TLR-activated innate immune responses from human T cells.
Sharma N; Akhade AS; Qadri A
Innate Immun; 2016 Apr; 22(3):238-44. PubMed ID: 26888964
[TBL] [Abstract][Full Text] [Related]
9. TLR-Mediated Innate Production of IFN-γ by CD8+ T Cells Is Independent of Glycolysis.
Salerno F; Guislain A; Cansever D; Wolkers MC
J Immunol; 2016 May; 196(9):3695-705. PubMed ID: 27016606
[TBL] [Abstract][Full Text] [Related]
10. Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.
Kumar S; Sunagar R; Gosselin E
Front Immunol; 2019; 10():1144. PubMed ID: 31191528
[TBL] [Abstract][Full Text] [Related]
11. The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses.
Chua BY; Olson MR; Bedoui S; Sekiya T; Wong CY; Turner SJ; Jackson DC
Immunol Cell Biol; 2014 Apr; 92(4):377-83. PubMed ID: 24394993
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2
Sales MC; Kasahara TM; Sacramento PM; Rossi ÁD; Cafasso MOSD; Oyamada HAA; Hygino J; Alvim F; Andrade RM; Cristina Vasconcelos C; Bento CAM
Immunology; 2021 Mar; 162(3):290-305. PubMed ID: 33112414
[TBL] [Abstract][Full Text] [Related]
13. A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells.
Santone M; Aprea S; Wu TY; Cooke MP; Mbow ML; Valiante NM; Rush JS; Dougan S; Avalos A; Ploegh H; De Gregorio E; Buonsanti C; D'Oro U
Hum Vaccin Immunother; 2015; 11(8):2038-50. PubMed ID: 26024409
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.
Bates JT; Graff AH; Phipps JP; Grayson JM; Mizel SB
J Immunol; 2011 Jun; 186(11):6255-62. PubMed ID: 21515787
[TBL] [Abstract][Full Text] [Related]
15. Gamma interferon secretion by human Vgamma2Vdelta2 T cells after stimulation with antibody against the T-cell receptor plus the Toll-Like receptor 2 agonist Pam3Cys.
Deetz CO; Hebbeler AM; Propp NA; Cairo C; Tikhonov I; Pauza CD
Infect Immun; 2006 Aug; 74(8):4505-11. PubMed ID: 16861636
[TBL] [Abstract][Full Text] [Related]
16. TLR agonist combinations that stimulate Th type I polarizing responses from human neonates.
Surendran N; Simmons A; Pichichero ME
Innate Immun; 2018 May; 24(4):240-251. PubMed ID: 29673285
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor-2/7-mediated T cell activation: An innate potential to augment CD8
Freen-van Heeren JJ
Scand J Immunol; 2021 May; 93(5):e13019. PubMed ID: 33377182
[TBL] [Abstract][Full Text] [Related]
18. Human monocytoid cells as a model to study Toll-like receptor-mediated activation.
Remer KA; Brcic M; Sauter KS; Jungi TW
J Immunol Methods; 2006 Jun; 313(1-2):1-10. PubMed ID: 16720029
[TBL] [Abstract][Full Text] [Related]
19. Treatment with ligands for toll-like receptors 2 and 5 induces a mixed T-helper 1- and 2-like response in chicken splenocytes.
St Paul M; Paolucci S; Sharif S
J Interferon Cytokine Res; 2012 Dec; 32(12):592-8. PubMed ID: 23030671
[TBL] [Abstract][Full Text] [Related]
20. A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity.
Leigh ND; Bian G; Ding X; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
PLoS One; 2014; 9(1):e85587. PubMed ID: 24454895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
